Akurate 133.5mg/58mg Tablet CR
Marketer
Affiance Drugs and Formulations
Salt Composition
Sodium Valproate (133.5mg) + Valproic Acid (58mg)
Overview Akurate 133.5mg/58mg Tablet CR
Epilepsy, a neurological condition marked by recurring seizures, is treated with the dual-action Akurate 133.5mg/58mg CR tablet. This medication regulates aberrant brain activity, promoting nerve relaxation and seizure prevention. Akurate 133.5mg/58mg CR tablets should be ingested with meals. Dosage, determined by your physician, may be gradually increased until your condition stabilizes. Therapeutic effects may take several weeks; consistent use is crucial. Discontinuation should only occur under medical supervision; cessation may trigger increased seizures or worsen existing bipolar disorder. Nausea and tremors are common side effects; others include vomiting, headaches, hepatic impairment, and upper abdominal discomfort. Most side effects are transient; persistent or bothersome effects necessitate medical consultation. Preventive or mitigating strategies may be available. Prior to commencing treatment, inform your doctor of any kidney or liver issues, meningitis, depression, or suicidal ideation. Disclose all other medications, including contraceptives, as interactions are possible. While pregnancy or breastfeeding doesn't preclude use, dosage adjustments may be necessary. Avoid driving or cycling if drowsiness or dizziness occurs. Regular blood tests monitor treatment efficacy. Alcohol consumption should be avoided due to potential side effect exacerbation. Weight gain is possible; maintain a balanced diet, limit high-calorie snacks, and incorporate regular exercise. Report any unusual mood shifts, new or worsening depression, or suicidal thoughts or actions to your doctor immediately.
Primary Ingredients of Akurate 133.5mg/58mg Tablet CR
No text was provided to rewrite.
Uses of Akurate 133.5mg/58mg Tablet CR
Seizure disorder
Major Benefits of Akurate 133.5mg/58mg Tablet CR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Akurate 133.5mg/58mg Tablet CR whole; do not chew, crush, or divide it. Administer this medication with a meal.
Common Side effects of Akurate 133.5mg/58mg Tablet CR:
- Nausea
- Tremors
How to use Akurate 133.5mg/58mg Tablet CR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Akurate 133.5mg/58mg Tablet CR whole; do not alter its form by chewing, crushing, or breaking. Administer this medication with food.
How Akurate 133.5mg/58mg Tablet CR works:
The extended-release tablet, Akurate 133.5mg/58mg CR, contains a dual anticonvulsant formulation of sodium valproate and valproic acid.
SAFETY ADVICE
AlcoholUNSAFE
Combining Akurate 133.5mg/58mg CR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Use of Akurate 133.5mg/58mg CR tablets is contraindicated during pregnancy due to established fetal risks. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Seek medical advice before use.
Breast feedingSAFE IF PRESCRIBED
Extended-release Akurate tablets (133.5mg/58mg) are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing no discernible risk to the infant.
DrivingUNSAFE
The extended-release Akurate 133.5mg/58mg tablet can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
The extended-release Akurate 133.5mg/58mg tablet is likely safe for individuals with kidney impairment. Current evidence indicates dose modification may be unnecessary, but this should be discussed with a physician. Patients with pre-existing kidney conditions should consult their doctor before using this medication.
LiverCAUTION
Patients with liver impairment should use Akurate 133.5mg/58mg CR tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Akurate 133.5mg/58mg CR tablets are contraindicated for those with severe or active liver disease.
What if you forget to take Akurate 133.5mg/58mg Tablet CR :
Should you forget to take your Akurate 133.5mg/58mg CR Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Akurate 133.5mg/58mg Tablet CR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
3,018 People bought this recently